![](/img/cover-not-exists.png)
Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer
Rosenberg, S. A., Lotze, M. T., Yang, J. C., Topalian, S. L., Chang, A. E., Schwartzentruber, D. J., Aebersold, P., Leitman, S., Linehan, W. M., Seipp, C. A., White, D. E., Steinberg, S. M.Volume:
85
Language:
english
Journal:
JNCI Journal of the National Cancer Institute
DOI:
10.1093/jnci/85.8.622
Date:
April, 1993
File:
PDF, 962 KB
english, 1993